This meeting is a joint event between the BioPharma Cluster South Germany and the German Society for Biochemistry and Molecular Biology (GBM) and the third in a successful series of events. In 2024, we will focus on Virus-based Therapies , highlighting and discussing the status, future opportunities and challenges of these novel and promising therapeutic approaches.
